Overview
At the UN HLM in New York (Sept 2026), India articulated its position on the PPPR. The declaration is part of the emerging global legal regime built around the PA. India’s remarks highlighted the need to protect national sovereignty while ensuring equitable access to health resources.
Key Developments
- India secured language that embeds multilateral components of the PA within the principle of national sovereignty.
- India called for equitable access to vaccines, therapeutics and digital health infrastructure as public goods.
- India emphasized active participation in the pending PABS annex.
- The United States rejected the declaration, viewing PABS and WHO’s pandemic‑declaration powers as a threat to its national interests.
Important Facts
The PA was adopted by 124 member‑states in 2025. No country voted against it; 11 abstained. Negotiations focused on three fault lines:
- Binding targets for One Health without guaranteed financing for fragile health systems.
- Harmonisation of national pandemic regulations through a global framework.
- Obligations on private manufacturers to share vaccines in real time at affordable prices.
The PA is not yet open for ratification because the PABS annex is still being negotiated.
Exam Relevance
Understanding the PA and PPPR is essential for GS2 (International Relations) as it reflects the dynamics between the Global North and South, and for GS3 (Health & Economy) because it deals with global health governance, vaccine equity, and the pharmaceutical supply chain. The debate over national sovereignty versus collective action ties into GS4 (Ethics) and the principle of multilateralism.
Way Forward for India
India can pursue three strategic options:
- Technical Partnerships: Build trust with other Global South nations by collaborating on One Health, surveillance and health‑workforce strengthening.
- Leverage Global Platforms: Use its influence in the H20 summit (a G‑7/G‑20 health partnership) and the Partners for Multilateralism initiative (EU‑co‑sponsored) to push for equitable pandemic policies.
- Domestic Alignment: Strengthen national regulations on access to biological material and benefit‑sharing, ensuring high standards of equity that can be advocated internationally.
India’s pharmaceutical capacity—manufacturing large volumes of vaccines but relying on foreign patents and APIs—makes an equitable global regime both a strategic interest and a responsibility. By championing South‑South cooperation and leading PABS negotiations, India can help shape a more inclusive global health architecture.